ShinKongHospital
Taipei, Taiwan
NCT Number: NCT03718962
Vitiligo is a relatively common acquired disorder of pigmentation characterized by the development of well-defined white macules on the skin. Biopsies of lesional skin reveal a loss of epidermal melanocytes. Lesions may occur in a localized or generalized distribution and may coalesce into large, depigmented areas. Given the contrast between the white areas and normal skin, the disease is most disfiguring in darker skin types and has a profound impact on the quality of life of both children and adults . Patients with vitiligo often experience stigmatization, social isolation, and low self-esteem. The therapys include topical steroids, topical immunosuppresant, systemic steroids, phototherapy, and surgery.
The aim of this study is to investigate the effect of phototherpy and accupuncture combined therapy for vitiligo patients.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Not applicable
Taipei, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Clinical diagnosis of Vitiligo
Exclusion criteria
Surrounding needling+ phototherapy
Other names: phototherapy
phototherapy
Time frame: 12weeks
repigmentation amount
Shin Kong Wu Ho-Su Memorial Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.